Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

506 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
IL-5 promotes eosinophil trafficking to the esophagus.
Mishra A, Hogan SP, Brandt EB, Rothenberg ME. Mishra A, et al. Among authors: rothenberg me. J Immunol. 2002 Mar 1;168(5):2464-9. doi: 10.4049/jimmunol.168.5.2464. J Immunol. 2002. PMID: 11859139
Chemokines in eosinophil-associated gastrointestinal disorders.
Hogan SP, Rothenberg ME, Forbes E, Smart VE, Matthaei KI, Foster PS. Hogan SP, et al. Among authors: rothenberg me. Curr Allergy Asthma Rep. 2004 Jan;4(1):74-82. doi: 10.1007/s11882-004-0047-8. Curr Allergy Asthma Rep. 2004. PMID: 14680626 Review.
Anti-interleukin-5 (mepolizumab) therapy for hypereosinophilic syndromes.
Garrett JK, Jameson SC, Thomson B, Collins MH, Wagoner LE, Freese DK, Beck LA, Boyce JA, Filipovich AH, Villanueva JM, Sutton SA, Assa'ad AH, Rothenberg ME. Garrett JK, et al. Among authors: rothenberg me. J Allergy Clin Immunol. 2004 Jan;113(1):115-9. doi: 10.1016/j.jaci.2003.10.049. Epub 2003 Dec 12. J Allergy Clin Immunol. 2004. PMID: 14699394 Clinical Trial.
Eosinophilic gastrointestinal disorders (EGID).
Rothenberg ME. Rothenberg ME. J Allergy Clin Immunol. 2004 Jan;113(1):11-28; quiz 29. doi: 10.1016/j.jaci.2003.10.047. J Allergy Clin Immunol. 2004. PMID: 14713902 Review.
506 results